Lifenity Group unveils integrated clinical pathology and genomic laboratory in Dubai

Lifenity Group unveils integrated clinical pathology and genomic laboratory in Dubai

Lifenity Group, has announced the launch of the integrated clinical pathology & genomic laboratory in the Middle East. This state-of-the-art laboratory located in Dubai will be dedicated to studying the profound impact that genome variations have on susceptibility to diseases, as well as the development and progression of diseases. The facility, located in Jumeirah Lake Towers (JLT), was inaugurated today in presence of the Chairman of Lifenity Group – Vijay Dhawangale, Managing Director – Nikhil Karkera, and Partner – Bankim Nanavati. Speaking about the significance of the laboratory, Vijay Dhawangale, Chairman of Lifenity Group, said: "We are proud to unveil our integrated clinical pathology and genomic laboratory, which exemplifies our commitment to revolutionize healthcare. Our integrated approach, cutting-edge technologies, and comprehensive testing services will serve patients in the field of genomic diagnostics. Through impactful research, we aim to advance preventive and predictive healthcare, making it accessible to everyone." Lifenity offers comprehensive testing services in-house to support patients’ complete diagnostics requirements. These services include LCMS (Complete Vitamin Profiling), haematology, biochemistry, microbiology, mycology, serology, preventive healthcare, immunochemistry, molecular, and diagnostic genomics. The lab will study a wide range of diseases and conditions in relation to genome variations and disease susceptibility. It will